Rarβ2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung

Clinical Epigenetics

Volumn 7, Issue 1, 2015, Pages 7-32

  Kim, Yujin ^a   Jin, Donghao ^a   Bin Lee, Bo ^a   Yoon Cho, Eun ^a   Han, Joungho ^a   Mog Shim, Young ^a   Kim, Duk Hwan ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

Lung cancer; Methylation; Never smoker; RAR 2; Recurrence

Indexed keywords

BETA CATENIN; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; RETINOIC ACID RECEPTOR BETA; SCATTER FACTOR RECEPTOR; UVOMORULIN;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN PROTEIN INTERACTION; PYROSEQUENCING; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RISK ASSESSMENT; SURVIVAL RATE;

EID: 84927130810     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1186/s13148-015-0066-4     Document Type: Article

References (29)

1. Jermal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
2. Kim JS, Kim JW, Han J, Shim YM, Park J, Kim DH. Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer. Cancer Res. 2006;66:4049-54.
3. Moghal N, Neel BG. Evidence of impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer. Mol Cell Biol. 1995;15:3945-59.
4. Bérard J, Laboune F, Mukuna M, Massé S, Kothary R, Bradley WE. Lung tumors in mice expressing an antisense RARbeta2 transgene. FASEB J. 1996;10:1091-7.
5. Toulouse A, Morin J, Dion PA, Houle B, Bradley WE. RARbeta2 specificity in mediating RA inhibition of growth of lung cancer-derived cells. Lung Cancer. 2000;28:127-37.
6. Virmani AK, Rathi A, Zöchbauer-Müller S, Sacchi N, Fukuyama Y, Bryant D, et al. Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. J Natl Cancer Inst. 2000;92:1303-7.
7. Zöchbauer-Müller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res. 2001;61:249-55.
8. Kim JS, Lee H, Kim H, Shim YM, Han J, Park J, et al. Promoter methylation of retinoic acid receptor beta 2 and the development of second primary lung cancers in non-small-cell lung cancer. J Clin Oncol. 2004;22:3443-50.
9. Kurie JM, Lotan R, Lee JJ, Lee JS, Morice RC, Liu DD, et al. Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trial. J Natl Cancer Inst. 2003;95:206-14.
10. Vermeulen SJ, Bruyneel EA, van Roy FM, Mareel MM, Bracke ME. Activation of the E-cadherin/catenin complex in human MCF-7 breast cancer cells by all-trans-retinoic acid. Br J Cancer. 1995;72:1447-53.
11. Byers S, Pishvaian M, Crockett C, Peer C, Tozeren A, Sporn M, et al. Retinoids increase cell-cell adhesion strength, beta-catenin protein stability, and localization to the cell membrane in a breast cancer cell line: a role for serine kinase activity. Endocrinol. 1996;137:3265-73.
12. Easwaran V, Pishvaian M, Salimuddin, Byers S. Cross-regulation of 3-catenin-LEF/TCF and retinoid signaling pathways. Curr Biol. 1999;9:1415-8.
13. Shah S, Hecht A, Pestell RG, Byers SW. Trans-repression of 3-catenin activity by nuclear receptors. J Biol Chem. 2003;278:48137-45.
14. Otero JJ, Fu W, Kan L, Cuadra AE, Kessler JA. Beta-catenin signaling is required for neural differentiation of embryonic stem cells. Dev 2004;131:3545-57.
15. Li Y, Wu RL, Wang X, Chen WS. Effects of retinoic acid on the signal transduction of beta-catenin/Tcf of cultured bronchial epithelial cells. Zhonghua Yi Xue Za Zhi. 2004;84:1130-1.
16. Liu T, Lee YN, Malbon CC, Wang HY. Activation of the beta-catenin/Lef-Tcf pathway is obligate for formation of primitive endoderm by mouse F9 totipotent teratocarcinoma cells in response to retinoic acid. J Biol Chem. 2002;277:30887-91.
17. Boyle JO, Langenfeld J, Lonardo F, Sekula D, Reczek P, Rusch V, et al. Cyclin D1 proteolysis: a retinoid chemoprevention signal in normal, immortalized, and transformed human bronchial epithelial cells. J Natl Cancer Inst. 1999;91:373-9.
18. Niu MY, Ménard M, Reed JC, Krajewski S, Pratt MA. Ectopic expression of cyclin D1 amplifies a retinoic acid-induced mitochondrial death pathway in breast cancer cells. Oncogene. 2001;20:3506-18.
19. Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res. 2004;64:8919-23.
20. Sonobe M, Manabe T, Wada H, Tanaka F. Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma. Br J Cancer. 2005;93:355-63.
21. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
22. Subramanian J, Govindan R. Molecular genetics of lung cancer in people who have never smoked. Lancet Oncol. 2008;9:676-82.
23. Rudin CM, Avila-Tang E, Harris CC, Herman JG, Hirsch FR, Pao W, et al. Lung cancer in never smokers: molecular profiles and therapeutic implications. Clin Cancer Res. 2009;15:5646-61.
24. Subramanian J, Govindan R. Lung cancer in ‘Never-smokers’: a unique entity. Oncol (Williston Park). 2010;24:29-35.
25. Yano T, Miura N, Takenaka T, Haro A, Okazaki H, Ohba T, et al. Never-smoking nonsmall cell lung cancer as a separate entity: clinicopathologic features and survival. Cancer. 2008;113:1012–8.
26. Lee HY, Chang YS, Han JY, Liu DD, Lee JJ, Lotan R, et al. Effects of 9-cis-retinoic acid on the insulin-like growth factor axis in former smokers. J Clin Oncol. 2005;23:4439–49.
27. Edge SB, Byrd DR, Compton CC, Fritz AF, Greene FL, Trotti A. American Joint Committee on cancer. In: AJCC cancer staging manual. 7th ed. New York: Springer; 2010. p. 253–70.
28. Ko E, Lee BB, Kim Y, Lee EJ, Cho EY, Han J, et al. Association of RASSF1A and p63 with poor recurrence-free survival in node-negative stage I-II non-small cell lung cancer. Clin Cancer Res. 2013;19:1204–12.
29. Lee ES, Issa JP, Roberts DB, Williams MD, Weber RS, Kies MS, et al. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance. Clin Cancer Res. 2008;14:2664–72.